Discovery of Aporphine Analogues as Potential Antiplatelet and Antioxidant Agents: Design, Synthesis, Structure-Activity Relationships, Biological Evaluations, and in silico Molecular Docking Studies
作者:Vashundhra Sharma、Pradeep K. Jaiswal、Surendra Kumar、Manas Mathur、Ajit K. Swami、Dharmendra K. Yadav、Sandeep Chaudhary
DOI:10.1002/cmdc.201800318
日期:2018.9.6
e,g]quinoline, 2‐ethoxy‐1,9,10‐trimethoxy‐6‐(methylsulfonyl)‐5,6,6a,7‐tetrahydro‐4H‐dibenzo[de,g]quinoline, 1‐ethoxy‐2,9,10‐trimethoxy‐6‐(methylsulfonyl)‐5,6,6a,7‐tetrahydro‐4H‐dibenzo[de,g]quinoline, 2,9,10‐trimethoxy‐6‐(methylsulfonyl)‐1‐propoxy‐5,6,6a,7‐tetrahydro‐4H‐dibenzo[de,g]quinoline, and 1‐(benzyloxy)‐2,9,10‐trimethoxy‐6‐(methylsulfonyl)‐5,6,6a,7‐tetrahydro‐4H‐dibenzo[de,g]quinoline were
为了探索紫花碱生物碱的潜力,提出了一系列新的功能化的紫花碱类似物,它们在A环的C1 / C2处带有烷氧基(OCH 3,OC 2 H 5,OC 3 H 7)官能团和一个酰基(COCH 3和COPh)或苯磺酰基(SO 2 P h和SO 2 C ^ 6 ħ 4 -3-CH 3)合成了Aporphine支架B环N6位的官能团,并评估了其对花生四烯酸(AA)诱导的抗血小板凝集抑制活性和2,2-二苯基-1-picylhydrazyl(DPPH)自由基清除抗氧化活性的作用,分别以乙酰水杨酸和抗坏血酸为标准。与AA诱导的血小板凝集抑制活性结果相关的初步构效关系表明,阿朴啡类似物1 [[1,2,9,10-四甲氧基-6 a,7-二氢-4 H-二苯并[ de,g ]]喹啉-6-(5 ħ) -基]乙酮和1- [2-(苄氧基)-1,9,10三甲氧基-6-一个,7-二氢-4- ħ -二苯并[de,g ]喹啉-6(5